Snapshot
- A 25-year-old man with a history of ulcerative colitis presents to his gastroenterologist. His ulcerative colitis had been calm but recently he developed rectal bleeding and increasingly frequent stools. A colonoscopy shows diffuse inflammatory changes localized to the rectum. He is started on topical mesalazine as well as oral sulfasalazine, which contains both an anti-inflammatory and anti-bacterial component.
Introduction
- Drugs
- sulfasalazine
- Mechanism of action
- activated by gut bacteria and metabolized into sulfapyridine and 5-aminosalicylic acid (5-ASA)
- 5-ASA
- anti-inflammatory (COX inhibitor)
- inhibits leukotriene synthesis and lipoxygenase
- sulfapyridine
- anti-bacterial
- Clinical use
- inflammatory bowel disease
- ulcerative colitis
- Crohn disease
- juvenile rheumatoid arthritis
- inflammatory bowel disease
- Adverse effects
- gastrointestinal upset
- drug rash
- hemolytic anemia in those with G6PD deficiency
- malaise
- reversible oligospermia
- contraindications
- allergy to sulfa medicines
- porphyria